These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 25044177)

  • 1. The PI3K/p-Akt signaling pathway participates in calcitriol ameliorating podocyte injury in DN rats.
    Song Z; Guo Y; Zhou M; Zhang X
    Metabolism; 2014 Oct; 63(10):1324-33. PubMed ID: 25044177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
    Zhang X; Song Z; Guo Y; Zhou M
    Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notoginsenoside R1 ameliorates podocyte injury in rats with diabetic nephropathy by activating the PI3K/Akt signaling pathway.
    Huang G; Lv J; Li T; Huai G; Li X; Xiang S; Wang L; Qin Z; Pang J; Zou B; Wang Y
    Int J Mol Med; 2016 Oct; 38(4):1179-89. PubMed ID: 27571993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
    Wang S; Li Y; Huang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway.
    Xiao H; Shi W; Liu S; Wang W; Zhang B; Zhang Y; Xu L; Liang X; Liang Y
    Am J Nephrol; 2009; 30(1):34-43. PubMed ID: 19202327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine ameliorates renal impairment and inhibits podocyte dysfunction by targeting the phosphatidylinositol 3-kinase-protein kinase B pathway in diabetic rats.
    Ni WJ; Zhou H; Ding HH; Tang LQ
    J Diabetes Investig; 2020 Mar; 11(2):297-306. PubMed ID: 31336024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The wnt/β-catenin signaling pathway participates in rhein ameliorating kidney injury in DN mice.
    Duan S; Wu Y; Zhao C; Chen M; Yuan Y; Xing C; Zhang B
    Mol Cell Biochem; 2016 Jan; 411(1-2):73-82. PubMed ID: 26346164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of podocyte ultrastructure and expression of podocyte-associated molecules in rats with diabetic nephropathy].
    Chen LP; Zhou QL; Peng WS; Wu XY
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):620-5. PubMed ID: 17767053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sweroside attenuates podocyte injury and proteinuria in part by activating Akt/BAD signaling in mice.
    Huang M; Yang Y; Chen Y; Li Y; Qin S; Xiao L; Long X; Hu K; Li Y; Ying H; Ding Y
    J Cell Biochem; 2023 Nov; 124(11):1749-1763. PubMed ID: 37796169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D prevents podocyte injury via regulation of macrophage M1/M2 phenotype in diabetic nephropathy rats.
    Zhang XL; Guo YF; Song ZX; Zhou M
    Endocrinology; 2014 Dec; 155(12):4939-50. PubMed ID: 25188527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.
    Trohatou O; Tsilibary EF; Charonis A; Iatrou C; Drossopoulou G
    J Cell Mol Med; 2017 Oct; 21(10):2599-2609. PubMed ID: 28664547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
    Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
    Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of angiotensin II receptor antagonist on rat podocyte injury in early diabetic nephropathy].
    Long HB; Zhong J; Wei LB; Zhou WD; Xu ZZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):505-8. PubMed ID: 17545045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of IRAK1 attenuates podocyte apoptosis in diabetic nephropathy through PI3K/Akt signaling pathway.
    Zhang Y; Chen X; Yuan L; Zhang Y; Wu J; Guo N; Chen X; Liu J
    Biochem Biophys Res Commun; 2018 Nov; 506(3):529-535. PubMed ID: 30361091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of ginsenoside Rgl on the expression of TNF-alpha and MCP-1 in rats with diabetic nephropathy].
    Zhang LN; Xie XS; Zuo C; Fan JM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):466-71. PubMed ID: 19627007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of podocyte-secreted angiopoietin-like-4 in diabetic nephropathy.
    Ma J; Chen X; Li JS; Peng L; Wei SY; Zhao SL; Li T; Zhu D; He YX; Wei QJ; Li B
    Endocrine; 2015 Jun; 49(2):373-84. PubMed ID: 25424436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
    Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
    Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.